Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fineman

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Diabetes Care|May 8, 1998
Gestational diabetes mellitus is associated with an increase in the total concentration of amylin moleculesN J Wareham, R Swinn, M S Fineman, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 14, 2005
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targetsR Ratner, F Whitehouse, M S Fineman, et al.
Ophthalmology|June 25, 2016
Early Optical Coherence Tomography Findings after Vitreomacular Traction ReleaseEhsan Rahimy, Abtin Shahlaee, David Ehmann, et al.
Retina (Philadelphia, Pa.)|July 2, 2019
PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDYCalvin Mein, Pravin U Dugel, Leonard Feiner, et al.
Diabetes Care|July 29, 2003
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetesMark S Fineman, Thomas A Bicsak, Larry Z Shen, et al.
Ophthalmology. Retina|June 26, 2026
Efficacy of Prophylactic Laser treatment of Lattice Degeneration in the Fellow Eyes of Patients with Retinal Break(s) in the First EyeRoselind L Ni, Olufemi E Adams, Bita Momenaei, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 11, 2005
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitusOrville G Kolterman, Dennis D Kim, Larry Shen, et al.
Metabolism: Clinical and Experimental|April 30, 2002
The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetesM S Fineman, J E Koda, L Z Shen, et al.
Radiology|March 1, 1989
Detection of abnormalities in febrile AIDS patients with In-111-labeled leukocyte and Ga-67 scintigraphyD S Fineman, C J Palestro, C K Kim, et al.
JAMA Ophthalmology|March 16, 2013
Electroretinographic effects of omega-3 Fatty Acid supplementation on dry age-related macular degenerationAdam T Gerstenblith, Darrell E Baskin, Chirag P Shah, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Diabetes Care|May 8, 1998
Gestational diabetes mellitus is associated with an increase in the total concentration of amylin moleculesN J Wareham, R Swinn, M S Fineman, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 14, 2005
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targetsR Ratner, F Whitehouse, M S Fineman, et al.
Ophthalmology|June 25, 2016
Early Optical Coherence Tomography Findings after Vitreomacular Traction ReleaseEhsan Rahimy, Abtin Shahlaee, David Ehmann, et al.
Retina (Philadelphia, Pa.)|July 2, 2019
PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDYCalvin Mein, Pravin U Dugel, Leonard Feiner, et al.
Diabetes Care|July 29, 2003
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetesMark S Fineman, Thomas A Bicsak, Larry Z Shen, et al.
Ophthalmology. Retina|June 26, 2026
Efficacy of Prophylactic Laser treatment of Lattice Degeneration in the Fellow Eyes of Patients with Retinal Break(s) in the First EyeRoselind L Ni, Olufemi E Adams, Bita Momenaei, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 11, 2005
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitusOrville G Kolterman, Dennis D Kim, Larry Shen, et al.
Metabolism: Clinical and Experimental|April 30, 2002
The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetesM S Fineman, J E Koda, L Z Shen, et al.
Radiology|March 1, 1989
Detection of abnormalities in febrile AIDS patients with In-111-labeled leukocyte and Ga-67 scintigraphyD S Fineman, C J Palestro, C K Kim, et al.
JAMA Ophthalmology|March 16, 2013
Electroretinographic effects of omega-3 Fatty Acid supplementation on dry age-related macular degenerationAdam T Gerstenblith, Darrell E Baskin, Chirag P Shah, et al.
Pageof 11